Frailty and mixture models in cancer screening evaluation
The prevalence of screen-detected premalignancies is too large for it to be feasible that all can progress to carcinoma at the same average rate, unless that rate is very low indeed. There are likely to be frailties in the rates of progression. Failure to take heterogeneity into account will lead to...
Main Author: | |
---|---|
Published: |
University College London (University of London)
2004
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.419873 |